COMMUNIQUÉS West-GlobeNewswire

-
argenx Announces Approval of VYVDURA (efgartigimod alfa and hyaluronidase-qvfc) in Japan for Adults with Chronic Inflammatory Demyelinating Polyneuropathy
27/12/2024 - 07:00 -
Park Ha Biological Technology Co., Ltd. Announces Pricing of $4.8 Million Initial Public Offering
27/12/2024 - 03:46 -
Viracta Therapeutics Announces Closure of NAVAL-1 Clinical Trial and Exploration of Strategic Alternatives
26/12/2024 - 22:30 -
Tevogen Bio to Host Panel Discussions “AI In Biopharma: Next Frontier of Medical Innovation” and “Pioneering the Economics of Health: Balancing Access and Outcomes” During J.P. Morgan Healthcare Conference
26/12/2024 - 18:21 -
Recover Red Introduces Portable Red Light Therapy Solution: The Power Stack
26/12/2024 - 16:54 -
TOMI Environmental Solutions Announces Additional CES Installation at a Pharmaceutical Facility in the UK
26/12/2024 - 15:15 -
Vivos Inc.’s IsoPet® Division Achieves Exceptional Growth in 2024, Expanding Certified Veterinary Clinics Nationwide
26/12/2024 - 14:30 -
Assembly Biosciences Reports Interim Phase 1b Results from Clinical Trial Evaluating Next-Generation Capsid Assembly Modulator Candidate ABI-4334 in Chronic Hepatitis B
26/12/2024 - 14:00 -
Optinose Announces 1-for-15 Reverse Stock Split
26/12/2024 - 13:00 -
TScan Therapeutics Announces $30 Million Registered Direct Offering at a 37% Premium
26/12/2024 - 13:00 -
Clearmind Medicine Looks to Move Forward with its Novel Psychedelic MEAI- Based Alcohol Substitute
26/12/2024 - 12:59 -
SciSparc: AutoMax Announces $13 Million First Delivery of JAC Vehicles Following Regulatory Approval for Direct Importation
26/12/2024 - 12:46 -
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
25/12/2024 - 17:40 -
Zealand Pharma major shareholder announcement: The Capital Group Companies, Inc.
25/12/2024 - 17:30 -
CorVel Announces Effectiveness of Three-For-One Forward Stock Split
24/12/2024 - 19:15 -
Achilles Therapeutics Announces Sale of Technology Assets to AstraZeneca
24/12/2024 - 15:30 -
Trinity Biotech Announces Amended Credit Agreement with Perceptive to Enhance Liquidity and Drive Transformation Plan
24/12/2024 - 14:33 -
Carmell Announces PIPE Investment From Existing and New Investors To Support Commercial Build-out
24/12/2024 - 14:30 -
LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock
24/12/2024 - 14:00
Pages